EN
抗体药类似物
Research Grade Nivatrotamab
All
  • CatalogTD-YP115066
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsBispecific,Hu3F8-BsAb,CAS:2278244-14-5
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Nivatrotamab


Catalog No. TD-YP115066
Species reactivity Human
Applications Research Grade Biosimilar
Host species Humanized
Isotype [H-gamma1-L-kappa-scFv heavy-kappa]-dimer
Expression system Mammalian Cells
Clonality Monoclonal
Target T3E, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E, T-cell surface glycoprotein CD3 epsilon chain
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession CAS: 65988-71-8 & P07766
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names Bispecific,Hu3F8-BsAb,CAS:2278244-14-5
Background Nivatrotamab (Hu3F8-BsAb) is a humanized anti-GD2/CD3 bispecific antibody. Nivatrotamab is a CD3- and GD2-specific bsAb-based T-cell engager. Nivatrotamab can be used in research of neuroblastoma.
Note For research use only. Not for use in clinical or therapeutic applications.